首页> 外文期刊>The Journal of Urology >Long-term followup of dextranomer/hyaluronic acid injection for vesicoureteral reflux: late failure warrants continued followup.
【24h】

Long-term followup of dextranomer/hyaluronic acid injection for vesicoureteral reflux: late failure warrants continued followup.

机译:右旋糖酐/透明质酸注射液对膀胱输尿管反流的长期随访:晚期失败值得继续随访。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: Dextranomer/hyaluronic acid injection of ureteral orifices is a popular option in the treatment of vesicoureteral reflux, with success rates ranging from 69% to 89%. We found only 1 study that followed patients beyond the initial postoperative voiding cystourethrogram, which describes a 96% success rate at 2 to 5 years but defines success as "nondilating" reflux. We examined our dextranomer/hyaluronic acid series to evaluate the long-term (1-year) outcome in children who had resolution of reflux on initial postoperative voiding cystourethrography. MATERIALS AND METHODS: We retrospectively reviewed our dextranomer/hyaluronic acid experience from February of 2002 to December of 2005. We determined initial success on early (6 to 12-week) postoperative voiding cystourethrogram. We then evaluated long-term success by obtaining a voiding cystourethrogram at 1 year postoperatively in patients who were initially cured of reflux. In addition, success rates between the first and second halves of our experience were evaluated to account for surgeon experience and modification of technique. RESULTS: Our total success rate at initial voiding cystourethrogram was 73% (246 of 337 total ureters). The success rate in the first half of our experience was 65.9% (112 of 170 ureters) and in the second half was 80.2% (134 of 167). A total of 150 ureteral units with initial successful dextranomer/hyaluronic acid treatment were evaluated at 1 year by voiding cystourethrogram. Of these ureters 111 had continued resolution of vesicoureteral reflux, for a long-term success rate of 74%. Including initial postoperative failures, the complete 1-year total success rate was 46.1% (111 of 241 ureters). CONCLUSIONS: Although the reflux resolution rates at initial postoperative voiding cystourethrogram approach those of open surgery, there is a significant failure rate at 1 year, which warrants long-term followup.
机译:目的:右旋糖酐/透明质酸注射输尿管口是治疗输尿管反流的一种普遍选择,成功率在69%至89%之间。我们发现只有1项研究对患者进行了随访,超出了患者术后最初的排尿膀胱电图,该研究描述了2至5年的成功率为96%,但将成功定义为“非扩张性”反流。我们检查了我们的右旋糖酐/透明质酸系列,以评估术后排尿初期膀胱尿道造影已确诊反流的儿童的长期(1年)结局。材料与方法:我们回顾性地回顾了我们从2002年2月至2005年12月的右旋糖酐/透明质酸的经历。我们确定了术后早期(6至12周)排尿膀胱尿道造影的初步成功。然后,我们通过对最初反流治愈的患者进行术后1年的膀胱尿道造影检查,获得长期成功率,以评估长期成功。此外,我们评估了上半部分和下半部分之间的成功率,以说明外科医生的经验和技术的改进。结果:我们在最初排尿膀胱尿道造影时的总成功率为73%(共337例输尿管中的246例)。我们上半年的成功率为65.9%(170名输尿管中的112名),而下半年的成功率为80.2%(167名中的134名)。于1年时通过排空膀胱神经电图评估了总共150例最初成功应用右旋糖酐/透明质酸治疗的输尿管单位。在这些输尿管中,111持续解决了输尿管反流,长期成功率为74%。包括最初的术后失败在内,完整的1年总成功率为46.1%(241位输尿管中的111位)。结论:尽管最初的术后排尿膀胱电描记图的反流分辨率接近开放手术,但在1年时有明显的失败率,值得长期随访。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号